CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Asthma - Management
Under 5 years
Children under 5 years of age with uncontrolled symptoms on current treatment: How do I manage?
- Adjust treatment using the step-wise approach outlined below.
- Before starting a new drug or stepping up treatment, confirm with the parents their understanding of the role of treatment, adherence to treatment, inhaler technique, and appropriate elimination of trigger factors.
- Choose an effective delivery system on the basis of convenience, cost, and suitability:
- Step 1: Prescribe a short-acting beta2-agonist to all children, for rapid symptom relief.
- Step 2: Consider starting an inhaled corticosteroid (ICS) at a dose that is appropriate for the severity of symptoms (usually equivalent to beclometasone CFC-free as Clenil Modulite® 200 to 400 micrograms/day). Indications for ICS include:
- Having symptoms three times weekly or more, or
- Awakening with symptoms one night weekly or more, or
- Having an exacerbation in the last 2 years, or
- Using inhaled short-acting beta2-agonist three times weekly or more.
- If ICS are not tolerated or are contraindicated, consider starting a leukotriene receptor antagonist at step 2 (but do so only in children aged 2–5 years).
- Step 3: If the child still has symptoms while using regular ICS (equivalent to Clenil Modulite® [beclometasone CFC-free] 400 micrograms/day), consider:
- For children younger than 2 years: move to step 4.
- For children aged 2–5 years: initiate a trial of a leukotriene receptor antagonist; if asthma remains inadequately controlled, move to step 4.
- Step 4: Refer to a paediatrician with knowledge about respiratory diseases.
- Offer self-management education, including written action plans focusing on the child's and the family's needs.
In depth
What follow up is recommended?
- Review a child with stable asthma at least once a year. More frequent follow up may be needed after the initial diagnosis, when there is a change to medication, or in children with severe asthma or recurrent exacerbations.
- Review asthma control:
- Ask about symptoms during the day; difficulty sleeping; and the impact of asthma on such activities as exercise and schooling in the past week or month.
- Ask about past exacerbations and their frequency, and whether oral corticosteroids or hospital admission was needed.
- Ask about possible trigger factors such as exercise and allergens.
- Ask about other conditions, that are known to co-exist with asthma and aggravate symptoms: for example, allergic rhinitis.
- Look for signs of complications which may necessitate referral to a specialist.
- Review asthma medication:
- Ask about the use of reliever medication, any benefits seen with changes in medication, and compliance with treatment.
- Assess the child's inhaler technique and check peak expiratory flow rate to compare with the previously recorded value.
- Review smoking habit. Encourage parents of children with asthma to stop smoking.
- Review self-management education and make any necessary changes to written action plans.
© NHS Institute for Innovation and Improvement